Financial Data and Key Metrics Changes - In Q4 2025, net sales were approximately $1.5 billion, a 4% increase from the prior year, primarily driven by higher raw material costs and favorable foreign currency translation [17] - Adjusted EBIT for the quarter was $150.6 million, relatively flat compared to the prior year, with adjusted EPS of $0.67, a decrease of $0.18 due to higher interest expense and tax rate [18] - Adjusted EBIT and EBITDA margins expanded by 150 basis points, positioning the company for accelerated growth in the coming years [12] Business Line Data and Key Metrics Changes - The Dispensing and Specialty Closures segment saw a 1% increase in sales, with higher volumes in fragrance and beauty products offset by destocking in personal care and home care markets [19] - Metal Containers segment sales increased by 11%, driven by a 4% growth in volumes, particularly in pet food products [20] - Custom Containers experienced an 8% decrease in sales due to lower margin business exit, but volumes increased by 1% when excluding these [21] Market Data and Key Metrics Changes - The company anticipates organic volume growth in Dispensing and Specialty Closures to be in the low to mid-single digits for 2026, with metal containers expected to grow by a low single-digit percentage [13] - The pet food market continues to drive growth, representing more than half of the metal containers segment volume [23] Company Strategy and Development Direction - The company successfully integrated the Weener acquisition, achieving full run rate synergies and positioning for organic growth exceeding peers [9] - Strategic initiatives are focused on operational excellence, market-leading innovation, and customer partnerships to drive future growth [15] - The company is optimistic about growth opportunities both organically and inorganically as it enters 2026 [12] Management's Comments on Operating Environment and Future Outlook - Management noted that 2025 was a challenging year due to evolving consumer spending trends, but the company adapted and strengthened processes for future agility [10] - The outlook for 2026 includes expectations for significant value creation for shareholders, with a focus on meeting unique customer needs [15] - Management has taken a conservative approach to guidance, considering broader market conditions and potential risks [62] Other Important Information - The company returned approximately $160 million in capital to shareholders and returned to its target leverage range following the Weener acquisition [8] - The company is focused on sustainability initiatives and cost reduction programs to enhance operational efficiency [62] Q&A Session Summary Question: Details on first quarter outlook for Dispensing and Specialty Closures - Management indicated low- to mid-single-digit volumes for the segment, with challenges from low-cost inventory impacting EBIT [29] Question: Changes in order patterns and operations in Dispensing and Specialty Closures - Management acknowledged that the business has evolved significantly, requiring a broader view of macro influences on customer demand [32] Question: Key volume and margin considerations at the low end of guidance - Management highlighted broader market conditions as a potential factor influencing demand and margins [36] Question: Performance of hot fill beverage and destocking impacts - Management confirmed that destocking activity is complete in the Dispensing and Specialty Closures segment, with expectations for stable volumes [40] Question: Growth opportunities in healthcare and pharma - Management expressed confidence in doubling the size of the healthcare business over the next few years, driven by strong market demand [66]

Financial Data and Key Metrics Changes - In Q4 2025, net sales were approximately $1.5 billion, a 4% increase from the prior year, primarily driven by higher raw material costs and favorable foreign currency translation [15][16] - Adjusted EBIT for the quarter was $150.6 million, relatively flat compared to the prior year, while adjusted EPS decreased by $0.18 to $0.67 due to higher interest expenses and tax rates [16] - Adjusted EBIT and EBITDA margins expanded by 150 basis points, positioning the company for accelerated growth in the coming years [11] Business Line Data and Key Metrics Changes - The Dispensing and Specialty Closures segment saw a 1% increase in sales, with higher volumes in fragrance and beauty products offset by destocking in personal and home care markets [16][17] - Metal Containers segment sales increased by 11%, driven by a 4% growth in volumes, particularly in pet food products [18][19] - Custom Containers experienced an 8% decrease in sales due to exiting lower-margin business, but volumes increased by 1% when excluding these [19] Market Data and Key Metrics Changes - The company anticipates organic volume growth in Dispensing and Specialty Closures to be in the low to mid-single digits for 2026, with metal containers expected to grow by a low single-digit percentage [12][21] - The pet food market continues to drive growth, representing more than half of the metal containers segment volume [21] Company Strategy and Development Direction - The company successfully integrated the Weener acquisition, achieving full run rate synergies and positioning for organic growth exceeding peers [6][8] - Strategic initiatives focus on operational excellence, market-leading innovation, and customer partnerships to drive future growth [7][12] - The company is optimistic about growth opportunities in both organic and inorganic avenues, particularly in healthcare and pharmaceuticals [11][62] Management's Comments on Operating Environment and Future Outlook - Management noted that 2025 was a challenging year due to evolving consumer spending trends, but the company adapted and strengthened processes for future agility [6][9] - The outlook for 2026 includes expectations for significant value creation for shareholders, with a focus on meeting customer needs and navigating market volatility [12][60] - Management has taken a conservative approach to guidance, incorporating broader market risks into their forecasts [60] Other Important Information - The company returned approximately $160 million in capital to shareholders and returned to its target leverage range post-acquisition [6] - The company expects free cash flow of approximately $450 million for 2026, with capital expenditures of about $310 million to support future growth [22] Q&A Session Summary Question: Details on first quarter outlook for Dispensing and Specialty Closures - Management indicated low- to mid-single-digit volume expectations, with challenges from low-cost inventory impacting EBIT [27][30] Question: Changes in order patterns and operations in Dispensing and Specialty Closures - Management acknowledged that the business has evolved, requiring a broader view of macro influences affecting customer demand [30][31] Question: Volume and margin considerations at the low end of guidance - Management highlighted broader market conditions as a potential factor influencing demand and margins [33] Question: Performance of hot fill beverage and destocking impacts - Management confirmed that destocking activity is complete in the Dispensing and Specialty Closures segment, with expectations for comparable volumes in 2026 [36][49] Question: Growth opportunities in healthcare and pharma - Management expressed confidence in doubling the size of the healthcare business over the next few years, driven by a strong pipeline and potential acquisitions [62][84]

Core Insights - Silgan Holdings Inc. reported full year 2025 net sales of $6.5 billion, a growth of 11% from $5.9 billion in 2024, and net income of $288.4 million, or $2.70 per diluted share, compared to $276.4 million, or $2.58 per diluted share in 2024 [1][16]. Financial Performance - For the fourth quarter of 2025, net sales were $1.47 billion, an increase of $57.4 million, or 4%, compared to the same period in 2024 [6]. - Adjusted net income per diluted share for the full year 2025 was $3.72, a 3% increase from $3.62 in 2024 [2]. - The company reported income before interest and income taxes (EBIT) of $597.9 million for 2025, up from $515.1 million in 2024 [17]. Segment Performance - The Dispensing and Specialty Closures segment generated net sales of $2.7 billion in 2025, a 17% increase from $2.3 billion in 2024, driven by the Weener acquisition and higher organic volumes [21]. - The Metal Containers segment saw net sales of $3.1 billion in 2025, an 8% increase from $2.9 billion in 2024, primarily due to favorable price/mix and higher volumes [23]. - The Custom Containers segment reported net sales of $637.6 million in 2025, a slight decrease of 2% from $649.6 million in 2024, attributed to lower volumes [25]. Cost Management and Efficiency - The company completed a multi-year cost savings program, which contributed to improved profitability across segments [3]. - Rationalization charges were $60.5 million in 2025, slightly higher than $59.5 million in 2024, indicating ongoing efforts to optimize operations [17]. Cash Flow and Capital Expenditures - Silgan generated net cash provided by operating activities of $729.8 million in 2025, compared to $721.9 million in 2024 [20]. - Free cash flow for 2025 was $445.2 million, a 14% increase from $391.3 million in 2024, driven by higher operating earnings [20]. Outlook for 2026 - The company estimates adjusted net income per diluted share for 2026 to be in the range of $3.70 to $3.90, reflecting a 2% increase at the midpoint compared to 2025 [27]. - Anticipated interest and other debt expense for 2026 is approximately $205 million, with an effective tax rate expected to be around 25-26% [28].

Group 1 - DSS, Inc. has commenced a public offering to sell shares of its Common Stock, with all shares being offered by the Company [1] - The net proceeds from the Offering will be used for general corporate and working capital needs [2] - Aegis Capital Corp. is acting as the sole book-running manager for the offering on a firm commitment basis [3] Group 2 - The offering is made pursuant to an effective shelf registration statement previously filed with the U.S. Securities and Exchange Commission (SEC) [3] - A final prospectus supplement and accompanying prospectus will be filed with the SEC and will be available on the SEC's website [3] - DSS, Inc. operates across multiple business lines including health and wellness, packaging, real estate, and securities and blockchain [5]

Core Insights - Amcor reported $5.45 billion in revenue for the quarter ended December 2025, marking a year-over-year increase of 68.1% [1] - The EPS for the same period was $0.86, compared to $0.80 a year ago, indicating a positive growth trend [1] - The revenue reported was a slight miss of -1.75% compared to the Zacks Consensus Estimate of $5.55 billion, while the EPS exceeded the consensus estimate of $0.83 by +3.61% [1] Revenue Performance - Net Sales for Flexible Packaging reached $3.19 billion, slightly above the three-analyst average estimate of $3.18 billion, reflecting a year-over-year change of +27% [4] - Net Sales for Rigid Packaging was reported at $2.26 billion, which was below the estimated $2.32 billion, but showed a significant year-over-year increase of +210.1% [4] Profitability Metrics - Adjusted EBIT for Rigid Packaging was $228 million, compared to the average estimate of $241.92 million from three analysts [4] - Adjusted EBIT for Flexible Packaging was reported at $402 million, slightly below the average estimate of $409.65 million [4] Stock Performance - Amcor's shares have returned +3.4% over the past month, outperforming the Zacks S&P 500 composite's +1.8% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Financial Data and Key Metrics Changes - Adjusted EPS increased by 7% for the quarter and 14% for the first half, reflecting strong execution against market opportunities [8][10] - Revenue for the quarter was $5.4 billion, with EBITDA of $826 million and EBIT of $603 million, significantly higher than the prior year due to the Berry acquisition and improved productivity [10][11] - Free cash flow was $289 million for the quarter, with a quarterly dividend declared at $0.65 per share, up from the prior year [11][24] Business Line Data and Key Metrics Changes - Global Flexible Packaging Solutions segment sales increased by 23% on a constant currency basis, while volumes were down approximately 2% [19][20] - Global Rigid Packaging Solutions segment sales also increased significantly, with volumes flat compared to the prior year, excluding non-core businesses [22][23] - Adjusted EBIT for the Flexible segment rose 22% on a constant currency basis to $402 million, while the Rigid segment's adjusted EBIT was $228 million, up over last year [21][23] Market Data and Key Metrics Changes - In developed regions, volume trends were down low- to mid-single digits, with Europe being more challenged than North America [20][22] - Emerging markets showed low single-digit growth in Asia Pacific, offset by lower volumes in Latin America [20] - Focus categories such as pet food and meat proteins performed better than the broader portfolio, while other categories like liquids and unconverted film and foil saw lower volumes [20][21] Company Strategy and Development Direction - The company is focused on delivering core business performance, accelerating synergy realization, and optimizing its portfolio, particularly the $2.5 billion of non-core businesses [9][10] - The acquisition of Berry is seen as a transformative step, positioning the company for long-term growth and value creation [5][9] - The company aims to deliver at least $260 million of synergies in fiscal 2026 and a total of $650 million by fiscal 2028 [16][28] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism for the second half, expecting volume performance to remain consistent with the first half, while focusing on cost control and productivity improvements [33][34] - The company reaffirmed its financial guidance for the fiscal year, with adjusted EPS expectations updated to $4.00-$4.15 per share [9][25] - Management noted that while the market environment remains challenging, they are well-positioned to capture revenue synergies and improve performance in non-core businesses [40][52] Other Important Information - The company has made significant progress in safety performance, with a total recordable incident rate of 0.52, and 79% of all sites remained injury-free [6][7] - The new CFO, Steve Scherger, has been actively engaged in understanding the business and is expected to contribute to value creation [16][18] Q&A Session Summary Question: Volume expectations for the next two quarters - Management indicated that they expect volume performance to be consistent with the first half, with some potential for upside from revenue synergies [33][34] Question: Fourth quarter initiatives for guidance confidence - Management highlighted seasonality, synergy growth, and expected improvements in non-core businesses as key drivers for EBIT improvement in the second half [39][40] Question: Volume performance in major categories - Management noted that overall company volumes were down 2.5%, with core portfolio volumes down 1.5%, indicating performance in line with broader industry trends [43][45] Question: Non-core business EBIT expectations - Management expects non-core EBIT margins to return to more traditional levels of 7%-9% in the second half, driven by improved contractual terms and operational performance [55][72] Question: Synergy capture details - Management confirmed that synergy capture was evenly split between G&A and procurement, with expectations for continued ramp-up in the second half [65][66]

Financial Performance - The company reported adjusted EPS growth of 7% for Q2 and 14% for the first half, indicating strong execution against market opportunities [8][10] - Revenue for the quarter was $5.4 billion, with EBITDA of $826 million and EBIT of $603 million, significantly higher than the prior year due to the Berry acquisition and improved productivity [10][11] - Free cash flow was $289 million for the quarter, with a quarterly dividend declared at $0.65 per share, reflecting a commitment to annualized dividend growth [11][24] Business Segment Performance - In the Global Flexible Packaging Solutions segment, sales increased by 23% on a constant currency basis, driven primarily by the Berry acquisition, although volumes were down approximately 2% [19][20] - The Global Rigid Packaging Solutions segment also saw significant sales growth due to the acquisition, with volumes flat compared to the prior year, indicating a sequential improvement [22][23] - Focus categories such as pet food and meat proteins performed better than the broader portfolio, while other categories like liquids and unconverted film saw lower volumes [20][23] Market Dynamics - Volume trends in developed markets showed low- to mid-single-digit declines, with Europe facing more challenges than North America [20][22] - Emerging markets experienced low single-digit growth in Asia Pacific, offset by declines in Latin America, indicating mixed performance across regions [20][22] - The core portfolio's volume performance was approximately 1.5% lower than the prior year, reflecting market dynamics that remain largely unchanged [12][42] Company Strategy and Competitive Position - The company is focused on delivering core business performance, accelerating synergy realization, and optimizing its portfolio, which includes evaluating alternatives for $2.5 billion of non-core businesses [7][10] - The company aims to deliver at least $260 million in synergies for fiscal 2026, with a total of $650 million expected by fiscal 2028 [16][26] - The core portfolio, which includes health, beauty, wellness, protein, liquids, food service, and pet care, is positioned for sustainable long-term growth [11][12] Management Commentary on Operating Environment and Future Outlook - Management expressed cautious optimism for the second half, expecting volume performance to remain consistent with the first half, while also focusing on cost management [31][32] - The company reaffirmed its financial guidance for fiscal 2026, with adjusted EPS expectations updated to $4.00-$4.15 per share, reflecting a commitment to double-digit EPS growth [9][25] - Management highlighted the importance of customer relationships and the need for a balance between price and volume in the current market environment [76] Other Important Information - The company has made significant progress in integrating the Berry acquisition, with a focus on operational synergies and cost management [15][16] - The new CFO, Steve Scherger, has been actively engaged in understanding the company's strategic priorities and operational capabilities [18][19] Q&A Session Summary Question: Expectations for volume performance in the next two quarters - Management indicated that they expect volume performance to be consistent with the first half, with some potential for upside from revenue synergies [31][32] Question: Initiatives for fourth quarter guidance - Management highlighted seasonality, synergy growth, and improvements in non-core businesses as key drivers for expected EBIT improvement in the second half [36][37] Question: Volume performance relative to the broader industry - Management noted that overall company volume performance was down 2.5%, which is in line with broader industry trends, with core portfolio volumes down 1.5% [40][42] Question: Improvement expectations for non-core EBIT contribution - Management expects non-core EBIT margins to return to more traditional levels in the second half, with improvements driven by better contractual terms and pricing [50][51] Question: Exit rates on volume performance - Management stated that focus categories collectively outperformed the core business, with pet care showing strong growth and healthcare experiencing some weakness due to a weaker flu season [55][56]

Financial Performance and Key Metrics - Adjusted EPS increased by 7% for the quarter and 14% for the first half, reflecting strong execution against market opportunities [6][10] - Revenue for the quarter was $5.4 billion, with EBITDA of $826 million and EBIT of $603 million, significantly higher than the prior year due to the Berry acquisition and improved productivity [9][10] - Free cash flow was $289 million for the quarter, with a quarterly dividend declared at $0.65 per share, up from the prior year [10][24] Business Line Performance - Global Flexible Packaging Solutions segment sales increased by 23% on a constant currency basis, driven primarily by the Berry acquisition, although volumes were down approximately 2% [19][20] - Global Rigid Packaging Solutions segment sales also increased significantly on a constant currency basis, with volumes flat compared to the prior year, excluding non-core businesses [21][22] - Focus categories such as pet food and meat proteins showed higher volumes, while other categories like liquids and unconverted film and foil experienced lower volumes [20][45] Market Performance - Volumes in developed regions like North America and Europe were down low- to mid-single digits, with Europe facing more challenges than North America [19][20] - Emerging markets showed low single-digit growth in Asia Pacific, offset by modestly lower volumes in Latin America [19][20] - The core portfolio's volume performance was approximately 1.5% lower than the prior year, with focus categories outperforming the broader portfolio [11][45] Company Strategy and Industry Competition - The company is focused on delivering core business, accelerating synergy realization, and optimizing its portfolio, which includes evaluating alternatives for $2.5 billion of non-core businesses [5][8] - The company aims to deliver at least $260 million of synergies in fiscal 2026 and a total of $650 million by fiscal 2028 [16][26] - The management emphasizes the importance of innovation and leadership positions in core categories to drive long-term consumer demand [11][12] Management Commentary on Operating Environment and Future Outlook - Management expressed cautious optimism for the second half, expecting volume performance to remain consistent with the first half, while focusing on cost control and productivity improvements [32][34] - The company reaffirmed its financial guidance for the fiscal year, with adjusted EPS expectations updated to $4.00-$4.15 per share [7][25] - Management noted that while the market environment remains challenging, there are opportunities for revenue synergies and improved performance in non-core businesses [34][50] Other Important Information - The company has made significant progress in reducing headcount by over 600 as part of its integration roadmap [13] - The acquisition of Berry has positioned the company as a global leader in consumer packaging and dispensing solutions, enhancing its competitive advantage [4][16] Q&A Session Summary Question: Expectations for volume performance in the next two quarters - Management indicated that they expect volume performance to be consistent with the first half, with some potential for improvement driven by revenue synergies [32][34] Question: Initiatives for the fourth quarter and confidence in guidance - Management highlighted seasonality, synergy growth, and improvements in non-core businesses as key drivers for expected EBIT improvement in the second half [39][40] Question: Volume performance in major categories and market share - Management noted that overall company volumes were down 2.5%, with core portfolio volumes down 1.5%, indicating performance in line with broader industry trends [42][43] Question: EBIT contribution from non-core businesses in the second half - Management expects EBIT margins for non-core businesses to return to more traditional levels of 7%-8%, representing a $50 million improvement compared to the first half [51][52] Question: Impact of GLP-1 on nutrition business - Management acknowledged the potential structural headwind from increased GLP-1 use but emphasized their positioning to support customers in balancing price and volume [86][87]

Fiscal 2026 Second Quarter Results Peter Konieczny Chief Executive Officer Steve Scherger Chief Financial Officer 3 February 2026 5:30pm US EST 4 February 2026 9:30am Australian EDT 1 Disclaimers and Notes Cautionary Statement Regarding Forward-Looking Statements Unless otherwise indicated, references to "Amcor," the "Company," "we," "our," and "us" in this document refer to Amcor plc and its consolidated subsidiaries. This document contains certain statements that are "forward-looking statements" within th ...

Core Insights - Amcor reported solid second quarter results for fiscal 2026, reaffirming its guidance for the year, with strong adjusted EPS growth driven by the Berry acquisition and disciplined execution [1][2][3] Financial Performance - For the three months ended December 31, 2025, net sales reached $5,449 million, a 68% increase year-over-year, primarily due to the Berry acquisition [1][2] - Adjusted EPS for the quarter was $0.86, up 7%, while adjusted EBITDA was $826 million, reflecting an 83% increase [1][2] - Free cash flow for the quarter was $289 million, including $69 million in acquisition-related costs [1][2] Fiscal Guidance - The company reaffirmed its fiscal 2026 guidance, expecting free cash flow between $1.8 billion and $1.9 billion and adjusted EPS in the range of $4.00 to $4.15, indicating a constant currency growth of 12% to 17% [1][2][3] Segment Performance - In the Global Flexible Packaging Solutions segment, net sales for the December 2025 quarter were $3,188 million, a 23% increase year-over-year on a constant currency basis [2][3] - The Global Rigid Packaging Solutions segment saw net sales of $2,264 million, a 200% increase year-over-year on a constant currency basis, driven by the Berry acquisition [3][4] Cost Management - Adjusted EBIT for the three months ended December 31, 2025, was $603 million, a 62% increase year-over-year, with synergy benefits from the Berry acquisition contributing approximately $50 million [1][2][3] - The company reported a GAAP net income of $177 million for the quarter, including acquisition-related costs [1][2] Dividend Declaration - Amcor declared a quarterly dividend of $0.65 per share, reflecting confidence in its growth opportunities and ability to generate significant free cash flow [2][3]